GBT
Neuberger Berman Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-236,158
| Closed | -$13M | – | 1729 |
|
|
2020
Q3 | $13M | Buy |
236,158
+2,000
| +0.9% | +$110K | 0.02% | 683 |
|
|
2020
Q2 | $14.8M | Buy |
234,158
+189,158
| +420% | +$11.9M | 0.02% | 633 |
|
|
2020
Q1 | $2.3M | Buy |
45,000
+2,499
| +6% | +$128K | ﹤0.01% | 914 |
|
|
2019
Q4 | $3.38M | Sell |
42,501
-27,499
| -39% | -$2.19M | ﹤0.01% | 923 |
|
|
2019
Q3 | $3.4M | Sell |
70,000
-16,800
| -19% | -$815K | ﹤0.01% | 910 |
|
|
2019
Q2 | $4.57M | Buy |
86,800
+35,300
| +69% | +$1.86M | 0.01% | 871 |
|
|
2019
Q1 | $2.73M | Buy |
51,500
+16,000
| +45% | +$847K | ﹤0.01% | 929 |
|
|
2018
Q4 | $1.46M | Buy |
35,500
+28,000
| +373% | +$1.15M | ﹤0.01% | 1040 |
|
|
2018
Q3 | $285K | Hold |
7,500
| – | – | ﹤0.01% | 1442 |
|
|
2018
Q2 | $339K | Sell |
7,500
-7,800
| -51% | -$353K | ﹤0.01% | 1473 |
|
|
2018
Q1 | $739K | Sell |
15,300
-7,200
| -32% | -$348K | ﹤0.01% | 1259 |
|
|
2017
Q4 | $885K | Buy |
+22,500
| New | +$885K | ﹤0.01% | 1255 |
|